Kok Hui Tan
CIK: 0001512616
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CYCC
Cyclacel Pharmaceuticals, Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (0 total)
2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Tan Kok Hui
Tan Kok Hui (SEC CIK 0001512616) files insider reports with the SEC as 10% Owner of Cyclacel Pharmaceuticals, Inc. (CYCC).
Signal8 holds 2 ownership filings by Tan Kok Hui, all Form 3s, filed between May 14, 2025 and May 30, 2025. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Tan Kok Hui's filings is in KUALA LUMPUR,, N8.
Other insiders filing for Cyclacel Pharmaceuticals, Inc. (CYCC)
- Kiu Cu Seng, CFO and Secretary
- Doris Wong Sing Ee, Chief Executive Officer
- Yap Kim Choy, 10% Owner
- Ong Yee Lung, 10% Owner
- Kua Khai Loon, 10% Owner
- Lazar David E., Interim CEO